Efficacy of geraniin on dengue virus type-2 infected BALB/c mice

Table 2 Spleen to body weight ratio of each mouse in the different treatment groups

Mouse	Ratio of spleen-to-body weight
Mouse	Uninfected and untreated (Control A)	Uninfected and geraniin treated (Control B)	Untreated DENV-2 infected (Infected A)	DENV-2 with geraniin at 24 h pre-infection (Infected B)	DENV-2 with geraniin at 24 h p.i. (Infected C)	DENV-2 with geraniin at 72 h p.i. (Infected D)
1	0.27	0.33	0.61	0.28	0.32	0.43
2	0.32	0.34	0.55	0.34	0.42	0.38
3	0.33	0.34	0.46	0.47	0.48	0.39
4	0.29	0.26	0.55	0.35	0.44	0.30
5	0.35	0.42	0.49	0.38	0.43	0.42
6	0.40	0.36	0.58	0.49	0.30	0.41
Mean	0.33	0.34	0.54	0.38	0.40	0.39

The body weight of each mouse was measured on the 8th day p.i. while the weight of each spleen was measured after the mice were sacrificed by cardiac puncture. The ratio of spleen-to-body weight of each mouse from the different groups were then calculated. The mean spleen-to-body weight ratio from six replicates mice were used to construct a bar chart of the effect of different geraniin treatments on the spleen of DENV-2 infected mice

ISSN: 1743-422X